The KAPA Tug-of-War: 2025’s Market Gains and Losses Analyzed

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook.

Kairos Pharma Ltd (KAPA) current stock price is $1.17. During the last trading session, the stock soared, reaching $12.0 after opening at $1.17. The stock’s lowest point was $4.0 before it closed at $1.07.

The market performance of Kairos Pharma Ltd has been somewhat unstable.

52-week price history of KAPA Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Kairos Pharma Ltd’s current trading price is -70.75% away from its 52-week high, while its distance from the 52-week low is 192.50%. The stock’s price range over this timeframe has been between $0.40 and $4.00. The shares of the Healthcare sector company recorded a trading volume of approximately 0.64 million for the day, which was comparatively lower than the average daily volume of 5.22 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Kairos Pharma Ltd (KAPA) has experienced a quarterly rise of 102.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 24.27M and boasts a workforce of 4 employees.

Expert Opinions: Analysts’ Ratings for Kairos Pharma Ltd

As of right now, 1 analyst is rating Kairos Pharma Ltd as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8096, with a change in price of +0.2486. Similarly, Kairos Pharma Ltd recorded 3,344,848 in trading volume during the last 100 days, posting a change of +26.98%.

KAPA Stock Stochastic Average

Kairos Pharma Ltd’s raw stochastic average for the past 50 days is currently at 51.49%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 71.88%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 60.08% and 63.09%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.